Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Bladder cancer is a histologically and clinically heterogenous disease. Most bladder
cancers are urothelial carcinomas, which frequently develop distinct histological subtypes …

Identifying the histologic subtypes and divergent differentiation in bladder cancer is
important to establish the correct diagnosis and classification and may also be clinically …

Simple Summary Bladder cancer (BC) possesses distinct molecular profiles that influence
progression depending on its biological nature and delivered treatment intensity. Muscle …

Bladder cancer researchers and clinicians have increasingly viewed tumor biology through
the lens of genomic and molecular alterations, drastically improving our knowledge of the …

Background Salivary duct carcinoma with rhabdoid features (SDC-RF) is a recently-
described salivary gland tumor that bears striking histologic similarity to lobular carcinoma of …

Non-urothelial bladder cancers make up a rare minority of all genitourinary (GU) tract
histologic cancers since urothelial cancer (UC) makes up the most common histologic …

Purpose Data about optimal management of plasmacytoid (PCV) bladder cancer patients
are extremely scarce and limited by sample size. We focused on PCV bladder cancer …

Objectives Plasmacytoid urothelial carcinomas (PUC) of the bladder are rare variants known
for diffuse and infiltrative spread, however their magnetic resonance imaging (MRI) features …

Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022
WHO classification of urinary tract tumors includes a list of less common subtypes (formerly …